Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2024 Earnings Call Transcript March 18, 2025
Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.69, expectations were $-0.87.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio Pharmaceuticals Fourth Quarter 2024 Financial Results Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This...
